J.P. Bru

2.2k total citations · 1 hit paper
45 papers, 925 citations indexed

About

J.P. Bru is a scholar working on Epidemiology, Pharmacology and Molecular Medicine. According to data from OpenAlex, J.P. Bru has authored 45 papers receiving a total of 925 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 12 papers in Pharmacology and 8 papers in Molecular Medicine. Recurrent topics in J.P. Bru's work include Antibiotics Pharmacokinetics and Efficacy (12 papers), Pneumonia and Respiratory Infections (11 papers) and Antibiotic Resistance in Bacteria (8 papers). J.P. Bru is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (12 papers), Pneumonia and Respiratory Infections (11 papers) and Antibiotic Resistance in Bacteria (8 papers). J.P. Bru collaborates with scholars based in France, Belgium and Morocco. J.P. Bru's co-authors include J.‐P. Stahl, R. Gauzit, Philippe Lesprit, Alexa Debard, Valérie Zeller, Aurélien Dinh, Catherine Chirouze, A. Therby, Philippe Aegerter and M. Dupon and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and Journal of Antimicrobial Chemotherapy.

In The Last Decade

J.P. Bru

44 papers receiving 886 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial

2014 315 citations Louis Bernard, Aurélien Dinh et al. The Lancet profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
J.P. Bru	380	340	171	140	130	45	925
E.T.M. Smyth	334 0.9×	387 1.1×	299 1.7×	123 0.9×	54 0.4×	37	1.2k
M.C. Kelsey	391 1.0×	191 0.6×	234 1.4×	62 0.4×	62 0.5×	51	920
Mervyn Shapiro	602 1.6×	496 1.5×	397 2.3×	89 0.6×	71 0.5×	53	1.6k
Chung-Jong Kim	357 0.9×	309 0.9×	336 2.0×	114 0.8×	131 1.0×	60	1.1k
Kordo Saeed	389 1.0×	206 0.6×	293 1.7×	148 1.1×	79 0.6×	76	1.0k
Victoire de Lastours	353 0.9×	146 0.4×	320 1.9×	91 0.7×	133 1.0×	74	1.1k
Brian E. Scully	489 1.3×	234 0.7×	361 2.1×	83 0.6×	393 3.0×	49	1.4k
David M. Bamberger	529 1.4×	270 0.8×	768 4.5×	60 0.4×	114 0.9×	45	1.5k
José Barberán	575 1.5×	331 1.0×	460 2.7×	109 0.8×	143 1.1×	121	1.3k
Thomas G. Slama	693 1.8×	259 0.8×	530 3.1×	168 1.2×	169 1.3×	33	1.4k

Countries citing papers authored by J.P. Bru

Since Specialization

Citations

This map shows the geographic impact of J.P. Bru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P. Bru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P. Bru more than expected).

Fields of papers citing papers by J.P. Bru

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.P. Bru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P. Bru. The network helps show where J.P. Bru may publish in the future.

Co-authorship network of co-authors of J.P. Bru

This figure shows the co-authorship network connecting the top 25 collaborators of J.P. Bru. A scholar is included among the top collaborators of J.P. Bru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.P. Bru. J.P. Bru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bru, J.P.. (2024). The role of systemic corticosteroids when treating infections in adult primary care. Infectious Diseases Now. 54(4). 104925–104925. 2 indexed citations

Lengliné, Étienne, J.P. Bru, Séverine Ansart, et al.. (2024). How do we respond to the threat of multidrug-resistant bacteria? Comparison of antibiotic appraisals from 2016 to 2020 of the French, English, and German HTA agencies. International Journal of Technology Assessment in Health Care. 40(1). e72–e72. 2 indexed citations

Stahl, J.‐P., Emmanuelle Varon, & J.P. Bru. (2022). Treatment of Coxiella burnetii endocarditis with hydroxychloroquine. Is it evidence-based?. Clinical Microbiology and Infection. 28(5). 637–639. 5 indexed citations

Gauzit, R., Bernard Castan, É. Bonnet, et al.. (2021). Anti-infectious treatment duration: The SPILF and GPIP French guidelines and recommendations. Infectious Diseases Now. 51(2). 114–139. 20 indexed citations

Lemaignen, Adrien, Louis Bernard, Pierre Tattevin, et al.. (2020). Oral switch versus standard intravenous antibiotic therapy in left-sided endocarditis due to susceptible staphylococci, streptococci or enterococci (RODEO): a protocol for two open-label randomised controlled trials. BMJ Open. 10(7). e033540–e033540. 15 indexed citations

Stahl, J.‐P., J.P. Bru, Jean-François Gehanno, et al.. (2020). Guidelines for the management of accidental exposure to Brucella in a country with no case of brucellosis in ruminant animals. Médecine et Maladies Infectieuses. 50(6). 480–485. 2 indexed citations

Bru, J.P., S. Alfandari, Alexandre Bleibtreu, et al.. (2019). Carbapenems versus beta-lactam/beta-lactamase inhibitors to treat ESBL-producing Enterobacteriaceae infections. Médecine et Maladies Infectieuses. 50(4). 313–315. 2 indexed citations

Robert, J., Y. Péan, S. Alfandari, et al.. (2017). Application of guidelines for aminoglycosides use in French hospitals in 2013–2014. European Journal of Clinical Microbiology & Infectious Diseases. 36(7). 1083–1090. 7 indexed citations

Montravers, Philippe, Hervé Dupont, Marc Léone, et al.. (2015). Prise en charge des infections intra-abdominales. Anesthésie & Réanimation. 1(1). 75–99. 11 indexed citations

10.

Alfandari, S., J. Robert, Y. Péan, et al.. (2015). Antibiotic use and good practice in 314 French hospitals: The 2010 SPA2 prevalence study. Médecine et Maladies Infectieuses. 45(11-12). 475–480. 16 indexed citations

11.

Gauzit, R., Y. Péan, S. Alfandari, et al.. (2015). Carbapenem use in French hospitals: A nationwide survey at the patient level. International Journal of Antimicrobial Agents. 46(6). 707–712. 18 indexed citations

12.

Bernard, Louis, Aurélien Dinh, Idir Ghout, et al.. (2014). Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial. The Lancet. 385(9971). 875–882. 315 indexed citations breakdown →

13.

Stahl, J.‐P., Dominique Salmon, Fabrice Bruneel, et al.. (2013). Adult patients hospitalized for measles in France, in the 21st century. Médecine et Maladies Infectieuses. 43(10). 410–416. 14 indexed citations

14.

Bru, J.P. & R. Garraffo. (2012). Role of intravenous cloxacillin for inpatient infections. Médecine et Maladies Infectieuses. 42(6). 241–246. 9 indexed citations

15.

Guillaume, Michel, et al.. (2012). Pharmacokinetic and dynamic study of levofloxacin and rifampicin in bone and joint infections. Médecine et Maladies Infectieuses. 42(9). 414–420. 13 indexed citations

16.

Dinh, Aurélien, et al.. (2008). Prescription de la fosfomycine en situation critique. Médecine et Maladies Infectieuses. 38(7). 383–386. 3 indexed citations

17.

Nicolle, Lindsay E., et al.. (2002). Three days of Pivmecillinam or Norfloxacin for Treatment of Acute Uncomplicated Urinary Infection in Women. Scandinavian Journal of Infectious Diseases. 34(7). 487–492. 54 indexed citations

18.

Gaillat, J., J.P. Bru, & A Sédallian. (1994). Penicillin G/ofloxacin versus erythromycin/amoxicillin-clavulanate in the treatment of severe community-acquired pneumonia. European Journal of Clinical Microbiology & Infectious Diseases. 13(8). 639–644. 11 indexed citations

19.

Stahl, J.‐P., et al.. (1988). Traitement des méningo-encéphalites à Listeria monocytogenes de l'adulte par le cotrimoxazole en monothérapie. La Revue de Médecine Interne. 9(1). 104–106. 4 indexed citations

20.

Bru, J.P., et al.. (1986). Accès pernicieux palustre. Evolution rapidement favorable après exsanguino-transfusion.. La Presse Médicale. 15(42). 2118–2118. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact